Johnson & Johnson agrees to settle opioid case in Ohio for $20 million

Johnson & Johnson agrees to settle opioid case in Ohio for $20 million
Johnson & Johnson and its Janssen Pharmaceutical subsidiary reached a deal worth more than $20 million with two Ohio counties - Cuyahoga and Summit - late Tuesday night to avoid trial in the opioid addiction crisis. The conglomerate is the fifth drug company to reach a settlement with the two counties in order to avoid the first federal trial over the nation's opioids crisis. J&J is not admitting liability in the settlement, which calls for the company to pay $10 million to the counties, and includes provisions for the company to reimburse the counties up to $5 million for legal expenses. The company will also contribute another $5.4 million to nonprofit organizations that deal with opioids.